Systemic lupus erythematosus: genetic variants in Xq28 region
More details
Hide details
Department of Clinical and Chemical Pathology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt
Department of Rheumatology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt
Submission date: 2019-10-03
Final revision date: 2019-10-14
Acceptance date: 2019-10-17
Online publication date: 2019-10-31
Publication date: 2019-11-19
Reumatologia 2019;57(5):264-270
Methyl-CpG-binding protein 2 (MECP2) and interleukin-1 receptor-associated kinase (IRAK1) are encoded by adjacent X-linked genes and recognized for their role in regulation of inflammation. The present case control study was conducted to detect the genetic association between MECP2 (rs1734791) and IRAK1 (rs1059703) single nucleotide polymorphisms (SNPs) and susceptibility to systemic lupus erythematosus (SLE), and the possible association of these SNPs and severity of SLE.

Material and methods:
Fifty patients with SLE and 100 healthy controls were included in this study. Systemic Lupus International Collaborating Clinics (SLICC) criteria were used to classify SLE patients and the activity of the disease was assessed by SLEDAI score. Disease severity was assessed by the SLICC damage index (SLICC DI). Genetic association of both SNPs with SLE was assessed by Taq Man allelic discrimination technique.

Analyses of MECP2 (rs1734791) SNP genotypes revealed that homozygous TT genotype was significantly higher in the control group than SLE patients (p < 0.001, odds ratio [OR] = 0.120). Frequency of allele (A) was significantly higher in SLE patients, (p < 0.001, OR = 0.334). SLE patients had significantly higher frequency of the homozygous AA and heterozygous AG genotype of IRAK1 (rs1059703) SNP in comparison to healthy controls (p = 0.0029, OR = 4.17 and 6.30 respectively). T+G and T+A of rs1734791 and rs1059703 SNPs are protective haplotypes (OR = 0.47 and 0.3, p = 0.0046 and < 0.012 respectively). No significant association between either SNP and disease activity or severity was found.

There is a possible genetic association between both rs1734791 and rs1059703 SNPs and susceptibility to SLE, while no significant association between either SNP and disease activity or severity was detected.

Hedrich CM. Epigenetics in SLE. Curr Rheumatol Rep 2017; 19: 58.
Miller FW, Alfredsson L, Costenbader KH, et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 2012; 39: 259-271.
Hedrich CM, Crispin JC, Tsokos GC. Epigenetic regulation of cytokine expression in systemic lupus erythematosus with special focus on T cells. Autoimmunity 2014; 47: 234-241.
Hedrich CM, Mabert K, Rauen T, Tsokos GC. DNA methylation in systemic lupus erythematosus. Epigenomics 2017; 9: 505-525.
Javierre BM, Fernandez AF, Richter J, et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010; 20: 170-179.
Koelsch KA, Webb R, Jeffries M, et al. Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. J Autoimmun 2013; 41: 168-174.
Young JI, Hong EP, Castle JC, et al. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methylCpG binding protein 2. Proc Natl Acad Sci U S A 2005; 102: 17551-17558.
Kaufman KM, Zhao J, Kelly JA, et al. Fine Mapping of Xq28: Both MECP2 and IRAK1 Contribute to Risk for Systemic Lupus Erythematosus in Multiple Ancestral Groups. Ann Rheum Dis 2013; 72: 437-444.
Hartupee J, Li X, Hamilton T. Interleukin 1alpha-induced NF kappa B activation and chemokine mRNA stabilization diverge at IRAK1. J Biol Chem 2008; 283: 15689-15693.
Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006; 6: 823-835.
Sawalha AM, Webb R, Han S, et al. Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus. PLoS One 2008; 3: e1727.
Webb R, Wren JD, Jeffries M, et al. Variants within MECP2, a key transcriptional regulator, are associated with increased susceptibility to lupus and differential gene expression in lupus patients. Arthritis Rheum 2009; 60: 1076-1084.
Alesaeidi S, Karami J, Mahmoudi M, et al. Methyl-CpG-Binding Protein 2 (MECP2) Polymorphism in Iranian Patients with Systemic Lupus Erythematosus. Inflammation 2015; 38: 2185-2190.
Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677-2686.
Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index. J Rheumatol 2002; 29: 288-291.
Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
Deng Y, Tsao BP. Advances in lupus genetics and epigenetics. Curr Opin Rheumatol 2014; 26: 482-492.
Della Ragione F, Vacca M, Fioriniello S, et al. MECP2, a multi-talented modulator of chromatin architecture. Brief Funct Genomics 2016; 15: 420-431.
Liu G, Tsuruta Y, Gao Z, et al. Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity. J Immunol 2007; 179: 4125-4134.
Liu G, Park YJ, Abraham E. Interleukin-1 receptor-associated kinase (IRAK) -1-mediated NF-kappaB activation requires cytosolic and nuclear activity. FASEB J 2008; 22: 2285-2296.
Heiseke AF, Jeuk BH, Markota A, et al. IRAK1 Drives Intestinal Inflammation by Promoting the Generation of Effector Th Cells with Optimal Gut-Homing Capacity. J Immunol 2015; 195: 5787-5794.
Kishi N, MacDonald JL, Ye J, et al. Reduction of aberrant NF-B signalling ameliorates Rett syndrome phenotypes in Mecp2-null mice. Nat Commun 2016; 7: 10520.
Li C, Jiang S, Liu SQ, et al. MeCP2 enforces Foxp3 expression to promote regulatory T cells’ resilience to inflammation. Proc Natl Acad Sci USA 2014; 111: E2807-2816.
O’Driscoll C, Kaufmann WE , Bressler J. Relationship between Mecp2 and NFb signaling during neural differentiation of P19 cells. Brain Res 2013; 1490: 35-42.
Barbhaiya M, Costenbader KH. Environmental Exposures and the Development of Systemic Lupus Erythematosus. Curr Opin Rheumatol 2016; 28: 497-505.
Walport MJ. Complement. N Engl J Med 2001; 344: 1058-1066.
Song WC. Crosstalk between Complement and Toll-Like Receptors. Toxicol Pathol 2012; 40: 174-182.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Journals System - logo
Scroll to top